HALEOS LABS LIMITED (NSE: HALEOSLABS), ISIN INE320X01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
HALEOSLABS last traded at ₹1546.00 (+1.56%), with a 52-week range of ₹1050.05 to ₹1778.35 (as of 30 Jul 2026).
Shareholding as of Mar 2026: promoters 72.11%, FIIs 0.00%, DIIs 0.30%, mutual funds 0.00%.
EquiSense Score (ECS): 32/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.